Eli Lilly continues radiopharma push with $140m Radionetics …

Jul 2, 2024 · The deal marks the latest push by Eli Lilly into the radiopharmaceuticals space. The company spent $1.4bn to buy POINT Biopharma in October 2023, gaining two late-stage …

CouponFollow Extension

$140
OFF

Eli Lilly Continues Radiopharma Push With $140m Radionetics …

4 weeks from now

Jul 2, 2024 · The deal marks the latest push by Eli Lilly into the radiopharmaceuticals space. The company spent $1.4bn to buy POINT Biopharma in October 2023, gaining two late-stage …

pharmaceutical-technology.com

$140
OFF

Radionetics Oncology Enters Into Strategic Agreement With Lilly

4 weeks from now

Jul 1, 2024 · Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals. Radionetics to receive $140 million upfront payment

businesswire.com

$140
OFF

Eli Lilly And Radionetics Oncology Enter $140m Radiopharma …

4 weeks from now

Jul 2, 2024 · Eli Lilly has agreed to pay Radionetics Oncology $140m upfront to partner on the biotech’s G protein-coupled receptor (GPCR)-targeting small-molecule radiopharmaceuticals. …

pmlive.com

$1
OFF

Eli Lilly Inks Another Radiopharma Deal, Gaining Option To Buy Startup

4 weeks from now

Jul 1, 2024 · Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 …

biopharmadive.com

$140
OFF

Eli Lilly Enters $140M Partnership With Radionetics Oncology

4 weeks from now

Jul 4, 2024 · During this exercise period, Radionetics will continue building and developing its pipeline of small molecule radioligands. This therapeutic modality, consisting of hitching a …

outsourcing-pharma.com

$140
OFF

Lilly Signs Another Radiopharma Pact | C&EN Global Enterprise

4 weeks from now

Jul 15, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

$140
OFF

Lilly Enters $140 Million Radiopharmaceutical Pact

4 weeks from now

Jul 11, 2024 · Eli Lilly and Company is backing another radiopharmaceutical developer, this time paying San Diego–based Radionetics $140 million up front to make drugs that target a family …

acs.org

$1
OFF

Eli Lilly & Co. Options Radionetics For $1B

4 weeks from now

Jul 8, 2024 · Eli Lilly and Company The relationship appears to be headed toward something more permanent with Lilly’s now exclusive right to acquire Radionetics following an exercise …

sdbj.com

$1
OFF

Eli Lilly Inks Deal Worth Over $1.1B To Develop New …

4 weeks from now

May 21, 2024 · Drugmaker Eli Lilly has inked a deal worth over $1 billion to develop new radiopharmaceuticals in concert with biotechnology firm Aktis Oncology. Under terms of the …

radiologybusiness.com

$60
OFF

Lilly Pays Aktis $60M To Further Dial Into Radiopharma Signal

4 weeks from now

May 21, 2024 · Lilly established itself as a player in the nascent radiopharma space by acquiring Point Biopharma for $1.4 billion late last year. The takeover included a manufacturing plant, …

fiercebiotech.com

FAQs about Eli Lilly continues radiopharma push with $140m Radionetics … Coupon?

Will Eli Lilly buy radionetics oncology for $140 million?

Eli Lilly is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G protein coupled receptor (GPCR) targeted drugs. ...

Why did Lilly acquire radionetics?

Radionetics provides Lilly access to proprietary GPCR targeting small molecule radiopharmaceuticals. Radionetics receives $140 million upfront payment and Lilly obtains the exclusive right to acquire Radionetics for $1 billion. We have a strong sense of purpose and urgency to discover new and innovative cancer treatment options. ...

What is Lilly doing with radionetics?

The biotech kicked off the Phase I study of 68Ga-R8760 in October 2023 and announced plans to launch clinical programs in breast and lung cancer. For Lilly, Monday’s partnership with Radionetics continues its recent investment spree in the radiopharma space. In October 2023, the pharma snapped up Point Biopharma for $1.4 billion. ...

How much will Lilly pay radionetics?

Lilly will pay Radionetics $140 million upfront for the option rights under the deal, which the companies announced Monday. Radionetics will continue to build its radiopharmaceutical drug pipeline through an “exercise period,” after which Lilly can choose whether to acquire the company. ...

Why is Lilly partnering with radionetics oncology?

"Furthering our commitment to radiopharmaceutical therapies, this relationship provides access to novel GPCR targets and the discovery capabilities of Radionetics Oncology," said Jacob Van Naarden, Executive Vice President and President, Lilly Oncology. ...

Where is Eli Lilly headquartered 2024?

A sign bearing Eli Lilly’s logo sits outside of the company’s headquarters on March 17, 2024 in Indianapolis, Indiana. Scott Olson via Getty Images Eli Lilly is expanding further into radiopharmaceuticals, inking a deal with Radionetics Oncology that gives it an option to later acquire the San Diego biotechnology company for $1 billion. ...